[English] 日本語

- PDB-5urn: NMR structure of the complex between the PH domain of the Tfb1 su... -
+
Open data
-
Basic information
Entry | Database: PDB / ID: 5urn | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
Title | NMR structure of the complex between the PH domain of the Tfb1 subunit from TFIIH and the transactivation domain 1 of p65 | |||||||||
![]() |
| |||||||||
![]() | TRANSCRIPTION / TRANSCRIPTION FACTOR TFIIH / TRANSACTIVATION DOMAIN / NUCLEAR FACTOR KAPPA-B / TRANSCRIPTIONAL ACTIVATION / P62/TFB1 SUBUNIT | |||||||||
Function / homology | ![]() prolactin signaling pathway / phosphatidylinositol-5-phosphate binding / DEx/H-box helicases activate type I IFN and inflammatory cytokines production / NF-kappaB p50/p65 complex / toll-like receptor TLR6:TLR2 signaling pathway / IkBA variant leads to EDA-ID / positive regulation of Schwann cell differentiation / nucleotide-excision repair factor 3 complex / response to cobalamin / cellular response to peptidoglycan ...prolactin signaling pathway / phosphatidylinositol-5-phosphate binding / DEx/H-box helicases activate type I IFN and inflammatory cytokines production / NF-kappaB p50/p65 complex / toll-like receptor TLR6:TLR2 signaling pathway / IkBA variant leads to EDA-ID / positive regulation of Schwann cell differentiation / nucleotide-excision repair factor 3 complex / response to cobalamin / cellular response to peptidoglycan / ankyrin repeat binding / Regulated proteolysis of p75NTR / CLEC7A/inflammasome pathway / SUMOylation of immune response proteins / RIP-mediated NFkB activation via ZBP1 / postsynapse to nucleus signaling pathway / negative regulation of protein sumoylation / phosphatidylinositol-3-phosphate binding / Interleukin-1 processing / nucleotide-binding oligomerization domain containing 2 signaling pathway / defense response to tumor cell / transcription factor TFIIH core complex / transcription factor TFIIH holo complex / cellular response to interleukin-6 / actinin binding / response to UV-B / non-canonical NF-kappaB signal transduction / negative regulation of non-canonical NF-kappaB signal transduction / positive regulation of miRNA metabolic process / Regulation of NFE2L2 gene expression / positive regulation of leukocyte adhesion to vascular endothelial cell / interleukin-1-mediated signaling pathway / NF-kappaB complex / signal transduction involved in regulation of gene expression / vascular endothelial growth factor signaling pathway / toll-like receptor 4 signaling pathway / positive regulation of amyloid-beta formation / RNA Pol II CTD phosphorylation and interaction with CE / Formation of the Early Elongation Complex / mRNA Capping / cellular response to hepatocyte growth factor stimulus / TP53 Regulates Transcription of DNA Repair Genes / RNA Polymerase II Promoter Escape / RNA Polymerase II Transcription Pre-Initiation And Promoter Opening / RNA Polymerase II Transcription Initiation / RNA Polymerase II Transcription Initiation And Promoter Clearance / RNA Polymerase II Pre-transcription Events / Formation of TC-NER Pre-Incision Complex / phosphate ion binding / positive regulation of T cell receptor signaling pathway / RNA Polymerase I Promoter Escape / cellular response to lipoteichoic acid / response to muramyl dipeptide / Gap-filling DNA repair synthesis and ligation in TC-NER / TRAF6 mediated NF-kB activation / positive regulation of vascular endothelial growth factor production / cellular response to angiotensin / Transcriptional Regulation by VENTX / The NLRP3 inflammasome / Dual incision in TC-NER / general transcription initiation factor binding / cellular response to interleukin-1 / hair follicle development / response to cAMP / canonical NF-kappaB signal transduction / neuropeptide signaling pathway / NF-kappaB binding / response to amino acid / cellular defense response / RNA polymerase II core promoter sequence-specific DNA binding / Purinergic signaling in leishmaniasis infection / NF-kB is activated and signals survival / transcription by RNA polymerase I / response to muscle stretch / response to cytokine / positive regulation of interleukin-12 production / antiviral innate immune response / peptide binding / negative regulation of cytokine production involved in inflammatory response / CD209 (DC-SIGN) signaling / response to interleukin-1 / negative regulation of insulin receptor signaling pathway / negative regulation of miRNA transcription / response to progesterone / negative regulation of angiogenesis / Dectin-1 mediated noncanonical NF-kB signaling / response to ischemia / Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells / animal organ morphogenesis / positive regulation of interleukin-1 beta production / Activation of NF-kappaB in B cells / tumor necrosis factor-mediated signaling pathway / negative regulation of extrinsic apoptotic signaling pathway / positive regulation of interleukin-8 production / TAK1-dependent IKK and NF-kappa-B activation / nucleotide-excision repair / RNA polymerase II transcription regulatory region sequence-specific DNA binding / transcription initiation at RNA polymerase II promoter / chromatin DNA binding / protein catabolic process Similarity search - Function | |||||||||
Biological species | ![]() ![]() ![]() | |||||||||
Method | SOLUTION NMR / simulated annealing | |||||||||
![]() | Lecoq, L. / Omichinski, J.G. / Raiola, L. / Cyr, N. / Chabot, P. / Arseneault, G. / Legault, P. | |||||||||
![]() | ![]() Title: Structural characterization of interactions between transactivation domain 1 of the p65 subunit of NF-kappa B and transcription regulatory factors. Authors: Lecoq, L. / Raiola, L. / Chabot, P.R. / Cyr, N. / Arseneault, G. / Legault, P. / Omichinski, J.G. | |||||||||
History |
|
-
Structure visualization
Structure viewer | Molecule: ![]() ![]() |
---|
-
Downloads & links
-
Download
PDBx/mmCIF format | ![]() | 890.3 KB | Display | ![]() |
---|---|---|---|---|
PDB format | ![]() | 744.3 KB | Display | ![]() |
PDBx/mmJSON format | ![]() | Tree view | ![]() | |
Others | ![]() |
-Validation report
Summary document | ![]() | 558.4 KB | Display | ![]() |
---|---|---|---|---|
Full document | ![]() | 2.2 MB | Display | |
Data in XML | ![]() | 301.9 KB | Display | |
Data in CIF | ![]() | 286.3 KB | Display | |
Arichive directory | ![]() ![]() | HTTPS FTP |
-Related structure data
Related structure data | ![]() 5u4kC C: citing same article ( |
---|---|
Similar structure data | |
Other databases |
|
-
Links
-
Assembly
Deposited unit | ![]()
| |||||||||
---|---|---|---|---|---|---|---|---|---|---|
1 |
| |||||||||
NMR ensembles |
|
-
Components
#1: Protein | Mass: 12903.701 Da / Num. of mol.: 1 / Fragment: PLECKSTRIN HOMOLOGY DOMAIN, UNP RESIDUES 2-115 Source method: isolated from a genetically manipulated source Source: (gene. exp.) ![]() ![]() Strain: ATCC 204508 / S288c / Gene: TFB1, YDR311W, D9740.3 / Production host: ![]() ![]() |
---|---|
#2: Protein/peptide | Mass: 3378.591 Da / Num. of mol.: 1 / Fragment: TRANSACTIVATION DOMAIN 1, UNP RESIDUES 521-551 / Mutation: L523Y Source method: isolated from a genetically manipulated source Details: The first GS residues come from a purification TAG. Source: (gene. exp.) ![]() ![]() ![]() |
-Experimental details
-Experiment
Experiment | Method: SOLUTION NMR | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
NMR experiment |
|
-
Sample preparation
Details |
| ||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sample |
| ||||||||||||||||||||||||||||||||||||
Sample conditions | Ionic strength: 0 mM / Label: Condition1 / pH: 6.5 / Pressure: AMBIENT / Temperature: 298 K |
-NMR measurement
NMR spectrometer |
|
---|
-
Processing
NMR software |
| |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Refinement | Method: simulated annealing / Software ordinal: 1 / Details: SIDECHAINS OPTIMIZATION WITH YASARA | |||||||||||||||||||||
NMR ensemble | Conformer selection criteria: structures with the lowest energy Conformers calculated total number: 260 / Conformers submitted total number: 20 |